Cargando…
Paving the way to improve therapy for Myeloproliferative Neoplasms
Long-acting IFNα induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFNα by targeting stem cell function or feedback loops that media...
Autores principales: | Bywater, Megan, Lane, Steven W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418146/ https://www.ncbi.nlm.nih.gov/pubmed/36028499 http://dx.doi.org/10.1038/s41467-022-32694-2 |
Ejemplares similares
-
Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues
por: Hautin, Marie, et al.
Publicado: (2020) -
Clonal Architecture in Myeloproliferative Neoplasms: Old Dog, New Tricks?
por: Godfrey, Anna L.
Publicado: (2023) -
Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2018) -
Gene Expression of CXCL1 (GRO-α) and EGF by Platelets in Myeloproliferative Neoplasms
por: Collinson, Ryan J., et al.
Publicado: (2020) -
MS-RIDD paves the way toward routine double bond localization in mass spectrometry-based lipidomics
por: Lamp, Leonida Marion, et al.
Publicado: (2022)